Yanling Feng

6PUBLICATIONS
53CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 15, 2025
Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.

Hua Tu, He Huang, Yanfang Li

|Jun 01, 2024
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial.

Rong Jiang, Yanling Feng, Yulian Chen

|Apr 12, 2024
QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.

Cheng Fang, Yun Zhou, Yanling Feng

|Aug 16, 2021
Perineural Invasion Should Be Regarded as an Intermediate-Risk Factor for Recurrence in Surgically Treated Cervical Cancer: A Propensity Score Matching Study.

Ting Wan, Hua Tu, Lili Liu

|Apr 07, 2021
The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.

Ting Deng, Qidan Huang, Ting Wan

|Aug 19, 2020
Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.

Rong Jiang, Jianqing Zhu, Jae Weon Kim

Pageof 1

Frequent Collaborators

2 joint publications

Rong Jiang

2 joint publications

Ting Wan

2 joint publications

Jihong Liu

2 joint publications

Hua Tu